JP Morgan Call 175 CHKP 19.07.202.../ DE000JB9AWD6 /
| 6/13/2024 8:32:14 AM | Chg.+0.010 | Bid10:00:37 PM | Ask10:00:37 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.037EUR | +37.04% | - Bid Size: - |
- Ask Size: - |
Check Point Software... | 175.00 USD | 7/19/2024 | Call |
GlobeNewswire
6/12
NKGen Biotech Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at ...
GlobeNewswire
6/12
OSE Immunotherapeutics KOL Investor Webinar on the Therapeutic Landscape and Unmet Medical Needs in ...
GlobeNewswire
6/12
PDS Biotech Provides Data Update from Ongoing VERSATILE-002 Phase 2 Clinical Trial in Head and Neck ...
GlobeNewswire
6/11
Check Point Software Simplifies Cloud Application Security with AI-Powered WAFaaS
GlobeNewswire
6/11
Bright Peak Therapeutics Announces $90 Million in Series C Financing to Advance First-in-Class PD1-I...
GlobeNewswire
6/10
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annu...
GlobeNewswire
6/10
Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FD...
GlobeNewswire
6/6
Scientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Reco...
GlobeNewswire
6/6
Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European...
GlobeNewswire
6/6
CHECKPOINT ALERT: Bragar Eagel & Squire, P.C. is Investigating Checkpoint Therapeutics, Inc. on Beha...
GlobeNewswire
6/5
Ocean Biomedical (NASDAQ: OCEA) Congratulates Joint Venture Partner, Virion Therapeutics, on Positiv...
GlobeNewswire
6/5
OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR...
GlobeNewswire
6/4
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Checkpoint Therapeutics, Inc. with Losse...
GlobeNewswire
6/4
Indaptus Therapeutics to Present New Positive Data on Decoy20 at Next-Gen Immuno-Oncology Conference
GlobeNewswire
6/4
CKPT DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Checkpoint Therapeutics, Inc. Investor...
GlobeNewswire
6/3
Ascendis Pharma Presents New Data and Updated Results from Phase 1/2 IL-Believe Trial at ASCO 2024
GlobeNewswire
6/3
7 Hills Pharma Receives $4.7MM Grant to Advance First-in-class Cell/Gene Therapy Technology into the...
GlobeNewswire
6/3
DEADLINE ALERT for CKPT, OCGN, SOND, QDEL: Law Offices of Howard G. Smith Reminds Investors of Class...
GlobeNewswire
6/3
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ch...
GlobeNewswire
6/3
DEADLINE ALERT for HRT and CKPT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions...
